Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

SCORCH2: A Generalized Heterogeneous Consensus Model for High-Enrichment Interaction-Based Virtual Screening.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025

Same author

AutoDock-SS: AutoDock for Multiconformational Ligand-Based Virtual Screening.

Journal of chemical information and modeling·2024

Same author

From intuition to AI: evolution of small molecule representations in drug discovery.

Briefings in bioinformatics·2023

Same author

Evidence that nuclear receptors are related to terpene synthases.

Journal of molecular endocrinology·2022

Same author

A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry <i>In Vitro</i> and <i>In Vivo</i>.

Journal of medicinal chemistry·2022

Same journal

Mapping Evolution of Molecules across Biochemistry with Assembly Theory.

Journal of chemical information and modeling·2026

Same journal

Structural Proteomics-Based Deciphering of Hydrophobic Packing Fingerprints Informing Protein Thermostability in TIM Barrels.

Journal of chemical information and modeling·2026

Same journal

Bridging between Structure-Based and Data-Driven Affinity Prediction.

Journal of chemical information and modeling·2026

Same journal

Reinforcement Learning-Driven Multiproperty Optimization in Molecular Design Using Multicontext Transcriptome Data.

Journal of chemical information and modeling·2026

Same journal

EnsembleCycPerm: Interpretable Modeling of Cyclic Peptide Permeability through Solvent-Dependent Conformational Ensembles.

Journal of chemical information and modeling·2026

Same journal

Resolving Conformational Preferences of Monosaccharides from <sup>1</sup>H and <sup>13</sup>C NMR Chemical Shifts Using an Integrated MD and QM Approach.

Journal of chemical information and modeling·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

UniDock-Pro: A Unified GPU-Accelerated Platform for High-Throughput Structure-Based, Ligand-Based, and Synergistic

Boyang Ni¹, Douglas R Houston¹

¹Institute for Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, U.K.

Journal of Chemical Information and Modeling

|February 24, 2026

Summary

This summary is machine-generated.

UniDock-Pro accelerates drug discovery by integrating structure-based, ligand-based, and hybrid screening. This GPU-accelerated platform processes millions of compounds daily, significantly improving early enrichment for efficient virtual screening.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Related Experiment Videos

Last Updated: Feb 25, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Area of Science:

Computational chemistry
Drug discovery
Bioinformatics

Background:

High-throughput computational tools are essential for screening ultralarge chemical libraries.
Existing methods require efficient exploitation of structural and chemical information.

Purpose of the Study:

To present UniDock-Pro, a unified platform for accelerated virtual screening.
To integrate structure-based virtual screening (SBVS), ligand-based virtual screening (LBVS), and a novel hybrid mode.
To enhance computational efficiency and accuracy in drug discovery.

Main Methods:

Developed UniDock-Pro, a GPU-accelerated platform based on Uni-Dock architecture.
Implemented enhanced LBVS with a smooth potential for gradient-based search.
Introduced a hybrid screening mode integrating receptor- and ligand-derived grid maps.
Developed Force Field Complementarity Analysis (FFCA) to quantify spatial alignment.

Main Results:

UniDock-Pro processes millions of compounds per day on a single GPU.
Achieved a 2.42-fold improvement in early enrichment (EF1%) over AutoDock-SS on the DUDE-Z benchmark.
Demonstrated strong early enrichment on DUDE-Z and competitive performance on VSDS-vd TrueDecoy benchmark using Hybrid mode.

Conclusions:

UniDock-Pro offers a robust, versatile, and highly efficient solution for drug discovery.
The platform significantly accelerates campaigns across large chemical spaces.
Enhanced LBVS and the novel hybrid mode improve virtual screening accuracy and speed.